$DECA News

Last published 1y ago

1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that on April 11, 2025, the Company's shareholders voted in favor of
1y agoDECADenali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.GlobeNewswireNEW YORK, NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that the Company's Extraordinary General Meeting of Shareholders (the
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
1y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
2y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
2y agoDECA SCLXSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and DenaliGlobeNewswireAs previously announced, Semnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (NASDAQ:DECA, the "SPAC")) entered into an agreement and plan of
2y agoDECA SCLXScilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned SubsidiaryGlobeNewswireScilex notified NASDAQ on October 28, 2024 that it has set a record date of November 7, 2024 (the "Record Date") for the dividend of Scilex preferred stock to Scilex's stockholders and certain other securityholders of
2y agoDECA SCLXSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 BillionGlobeNewswireSemnur is currently in discussions regarding strategic regional and/or worldwide collaborations and potential outright acquisition of SP-102. Any such transactions may have the potential to provide value in excess of
2y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
2y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
2y agoDECA SCLXSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 BillionGlobeNewswireSemnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company (NASDAQ:SCLX, "Scilex")), and Denali Capital Acquisition Corp. (NASDAQ:DECA, the "SPAC")) announce the signing of an agreement
2y agoDECA SCLXSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business CombinationGlobeNewswireSemnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company (NASDAQ:SCLX, "Scilex")), and Denali Capital Acquisition Corp. (NASDAQ:DECA, the "SPAC")) announce the signing of an agreement
2y agoDECA SCLXDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an
2y agoDECADenali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that the Company's shareholders voted in favor of approving amendments to the
2y agoDECA SCLXSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business CombinationGlobeNewswireSemnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company (NASDAQ:SCLX, "Scilex")), and Denali Capital Acquisition Corp. (NASDAQ:DECA) ("SPAC") announce signing of a letter of intent
2y agoDECADenali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business CombinationGlobeNewswireNEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed to
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's trust account to
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's trust account to
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswireNEW YORK, NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's trust account to
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationPR NewswireDenali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's...
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationPR NewswireDenali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's...
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationPR NewswireDenali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's...
2y agoDECADenali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024PR NewswireDenali Capital Acquisition Corp. (Nasdaq: DECA) (the "Company") announced today that its previously announced extraordinary general meeting (the...
2y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationPR NewswireDenali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's...
3y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationPR NewswireDenali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's...
3y agoDECA DECAUDenali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business CombinationPR NewswireNEW YORK, Oct. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that the Company's shareholders voted in favor of approving amendments to the
3y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business CombinationPR NewswireNEW YORK, July 13, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA) ("Denali" or the "Company") announced today that an aggregate of $825,000 has been deposited into the Company's
3y agoDECADenali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business CombinationPR NewswireNEW YORK, July 7, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA) ("Denali" or the "Company") announced today that it intends to deposit into the Company's trust account an
3y agoDECADenali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business CombinationPR NewswireNEW YORK, April 12, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA) ("Denali" or the "Company") announced today that it has deposited into the Company's trust account an aggregate
3y agoDECA DECAUDenali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business CombinationPR NewswireNEW YORK, April 6, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA) ("Denali" or the "Company") announced today that it intends to deposit into the Company's trust account an
3y agoDECALongevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and LongevityPR Newswire- Longevity Biomedical is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and
3y agoDECALongevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and LongevityPR NewswireLongevity Biomedical is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services
4y agoDECA DECAUDenali Capital Acquisition Corp. Announces Pricing of $75 Million Initial Public OfferingPR NewswireNEW YORK, April 6, 2022 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ:DECA, the ", Company", ))) announced today that it priced its initial public offering ("IPO") of 7,500,000 units at a price of $10.00 per unit. The units have been approved